In summary, we found 2 germline PALB2 deleterious mutation carriers in 122 high risk non-BRCA1 or BRCA2 breast cancer patients by DNA sequencing and 1 germline carrier in 1406 breast cancer patients by genotyping. The gene discussed is BRCA2; the disease is breast cancer.